Xeris Biopharma Holdings Inc. – Filings and Transcripts

NASDAQ: XERS
Share price (11/6/26): $15.20
Market cap (11/6/26): $2.777 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/26 Q3

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Shelf registration

Registration of securities for employees

Registration of securities for employees

Ownership Filter

McCulloch Kevin

McCulloch Kevin

McCulloch Kevin

News Filter

Reports Third Quarter 2026 Financial Results and Business Highlights

Welcomes Menassie M. Taddese to Board of Directors

Hosts Webinar Detailing Its Comprehensive Development Program for Xp-8121, an Investigational, Once-Weekly Subcutaneous Levothyroxine for Hypothyroidism

Reports Second Quarter 2026 Financial Results

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Scanned paper annual report submission

Letter from the SEC